Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Damon

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Nature Communications|June 28, 2023
A landscape of response to drug combinations in non-small cell lung cancerNishanth Ulhas Nair, Patricia Greninger, Xiaohu Zhang, et al.
Genes & Development|October 16, 2020
Selective inhibition of CDK7 reveals high-confidence targets and new models for TFIIH function in transcriptionJenna K Rimel, Zachary C Poss, Benjamin Erickson, et al.
Nature Medicine|February 2, 2016
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibitionAaron N Hata, Matthew J Niederst, Hannah L Archibald, et al.
Cancer Discovery|May 28, 2016
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic CholangiocarcinomaSupriya K Saha, John D Gordan, Benjamin P Kleinstiver, et al.
Cell|June 4, 2019
Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic CancerMatteo Ligorio, Srinjoy Sil, Jose Malagon-Lopez, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Nature Communications|June 28, 2023
A landscape of response to drug combinations in non-small cell lung cancerNishanth Ulhas Nair, Patricia Greninger, Xiaohu Zhang, et al.
Genes & Development|October 16, 2020
Selective inhibition of CDK7 reveals high-confidence targets and new models for TFIIH function in transcriptionJenna K Rimel, Zachary C Poss, Benjamin Erickson, et al.
Nature Medicine|February 2, 2016
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibitionAaron N Hata, Matthew J Niederst, Hannah L Archibald, et al.
Cancer Discovery|May 28, 2016
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic CholangiocarcinomaSupriya K Saha, John D Gordan, Benjamin P Kleinstiver, et al.
Cell|June 4, 2019
Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic CancerMatteo Ligorio, Srinjoy Sil, Jose Malagon-Lopez, et al.
Pageof 7